Vitafol Nano By Exeltis USA Overview & Drug Interactions

Check For Interactions With Vitafol Nano

Supplement: Vitafol Nano by Exeltis USA

Vitafol Nano Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Vitafol Nano by Exeltis USA

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 30
UPC/BARCODE 306420094309

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin D
1000 IU
Vitamin D (cholecalciferol) 250%
Vitamin B6
2.5 mg
Vitamin B6 100%
Folate
1 mg
Vitamin B9 (Folate) 125%
Folic Acid
0.4 mg
Vitamin B9 (folic acid)
L-Methylfolate Calcium
0.6 mg
Vitamin B9 (5-Methyltetrahydrofolate)
Vitamin B12
12 mcg
Vitamin B12 (cyanocobalamin) 150%
Iron
18 mg
Iron 100%
Iodine
150 mcg
Iodine 100%

Other Ingredients:
Microcrystalline Cellulose
Hydroxypropylcellulose
modified Food Starch
Croscarmellose Sodium
Magnesium Stearate
Sucrose
Silicon Dioxide
Dibasic Calcium Phosphate
Polyvinyl Alcohol
Titanium Dioxide
Polyethylene Glycol
Talc
Sodium Ascorbate
Medium Chain Triglycerides
D-Alpha Tocopherol
Sucralose
FD&C Blue #2 Aluminum Lake


Label Statments:


Formulation
- Usage: Vitafol-Nano provides vitamin and mineral supplementation prior to conception throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.
- Essential nutrients in a tolerable form without DHA
Precautions
- Warning: Accidental overdose of iron-containing product is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a poison control center immediately.
Suggested/Recommended/Usage/Directions
- Directions for Use: Before, during and after pregnancy, one tablet day, or as directed by a physician.
General Statements
- How Supplied: Vitafol-Nano is available as a light blue, round tablet imprinted with "94" on one side. Available in box of unit-dose pack of 30 (2 child resistant blister cards of 15 tablets), 0642-0094-30 and as professional samples, 0642-0094-03.
- Rx See package insert for full prescribing information
- Unit dose pack
- 0642-0094-30
Storage
- Store at controlled room temperature 20 degrees - 25 degrees C (68 degrees - 77 degrees F). Avoid excessive heat, light, moisture and humidity.
Brand IP Statement(s)
- Copyright 2019 Exeltis USA, Inc Vitafol is a trademark of Exeltis USA, Inc. U.S. Patent Pending Metafolin is a trademark of Merck KGaA Darmstadt, Germany U.S. Patent No. 6,441,16881; 5,997,915; 6,254,904; 6,808,725; 7,172,778 and 7,674,490
Formula
- Smallest prenatal supplement with essential nutrients
- Usage: Vitafol-Nano provides vitamin and mineral supplementation prior to conception throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.
FDA Statement of Identity
- Dietary Supplement

Brand Information

See all products by this brand

Distributed by
Name Exeltis USA, Inc.
City Florham Park
State NJ
ZipCode 07932
Phone Number 1-877-324-9349
Web Address www.exeltisUSA.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.